Bitting, Rhonda L.

Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide

Noonan, K. L., North, S., Bitting, R. L., Armstrong, A. J., Ellard, S. L., & Chi, K. N. (2013) · Annals of Oncology

Prostate Cancer Treatment and ResearchBone health and treatments

Cited by 343

Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology

Spratt, D. E., Srinivas, S., Adra, N., Ahmed, B., An, Y., Bitting, R., Chapin, B., Cheng, H. H., Cho, S. Y., D’Amico, A. V., et al. (2025) · Journal of the National Comprehensive Cancer Network

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 146

Germline and somatic genomic testing for metastatic prostate cancer: ASCO guideline

Yu, E. Y., Rumble, R. B., Agarwal, N., Cheng, H. H., Eggener, S. E., Bitting, R. L., Beltran, H., Giri, V. N., Spratt, D., Mahal, B., et al. (2025) · Journal of Clinical Oncology

Prostate Cancer Treatment and ResearchCancer Genomics and Diagnostics

Cited by 64

Genomic classifiers and prognosis of localized prostate cancer: a systematic review

Boyer, M. J., Carpenter, D. J., Gingrich, J. R., Raman, S. R., Sirohi, D., Tabriz, A. A., Rompre-Broduer, A., Lunyera, J., Basher, F., Bitting, R. L., et al. (2025) · Prostate Cancer and Prostatic Diseases

Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and Research

Cited by 22